Summary
The studies deal with electrophysiological effects of asocainol [(±)-6,7,8,9-tetrahydro-2,12-dimethoxy-7-methyl-6-phenetyl-5H-dibenz(d,f)azonine-1-ol] on isolated perfused guinea-pig hearts (Langendorff-preparation), on right ventricular papillary muscles, on Purkinje fibres from the guinea pig, and on isolated sinus nodes from the rabbit.
In the perfused heart (n=5) the lowest effective concentration of asocainol is about 0.2 μmol/l. At a concentration of 2 μmol/l the cardiac electrogram shows in spontaneously beating hearts a mean decrease in frequency of 15%, in electrically driven hearts (150/min at 32°C) prolongation of PQ (+31%), of QRS (+24%) and of QT (+5%).
In papillary muscles (32° C; K +e 5.9 mmol/l; stimulation rate 0.5 Hz) asocainol (3–30 μmol/l) exerts the following effects: no change of the resting potential, concentration-dependent reduction of the maximum rate of rise \(\dot V_{max} \) of the action potential (AP) (−16 to −67%) as well as of the AP-amplitude (−4 to −16%), and shortening of the AP-duration at 50% repolarisation (−18 to −43%). The steady-state dependence of \(\dot V_{max} \) on the resting potential (RP) determined by variation of K +e (5.9–15 mmol/l) is shifted by asocainol to more negative potentials. The percentage deviation from controls of the \(\dot V_{max} \)-RP relationship is more pronounced at lower membrane potentials. The influence of asocainol on the recovery from inactivation of \(\dot V_{max} \) shows marked time-dependence. Slow response (Ca2+-mediated) APs elicited by strong stimuli in a K +e -rich solution (K +e 20–24 mmol/l) respond to asocainol (3–10 μmol/l) with a marked reduction in amplitude, \(\dot V_{max} \) and duration. In Purkinje fibres the spontaneous activity occurring in K +e 2 mmol/l (37°C) is suppressed by asocainol (3–10 μmol/l). The excitatory parameters are affected in a way essentially similar to that in papillary muscles. In the primary pacemaker region of the sinus node of the rabbit (37°C) asocainol (10–20 μmol/l) reduces the rate of the diastolic depolarisation and diminishes the amplitude and the upstroke velocity of the AP. All the effects of asocainol are only partially reversible by drug-free superfusion for 3 h.
The various electrophysiological effects of asocainol are attributed to inhibitory influences of the drug on the fast and on the slow inward current.
Similar content being viewed by others
References
Antoni H (1983) Pathophysiologie der Herzrhythmusstörungen. Cardiology 70:1–10
Bean BP, Cohen CJ, Tsien RW (1982) Block of cardiac sodium channels by tetrodoxin and lidocaine. Sodium current and \(\dot V_{max} \) experiments. In: Paes de Carvalho A, Hoffmann BF, Liebermann M (eds) Normal and abnormal conduction in the heart. Futura Publishing Company. Mount Kisco New York, pp 189–206
Chen CM, Gettes LS (1976) Combined effects of rate membrane potential and drugs on maximal rate of rise \(\dot V_{max} \)of action potential upstroke of guinea pig papillary muscle. Circ Res 38:464–469
Chen CM, Gettes LS, Katzung BG (1975) Effect of lidocaine and quinidine on steady-state characteristics and recovery kinetics of (dV/dt)max in guinea pig ventricular myocardium. Circ Res 37:20–29
Cohen IS, Strichartz GR (1977) On the voltage-dependent action of tetrodotoxin. Biophys J 17:275–279
Courtney KR (1980a) Structure-activity relations for frequency-dependent sodium channel block in nerve by local anaesthetics. J Pharmac Exp Ther 213:114–119
Courtney KR (1980b) Interval-dependent effects of small antiarrhytmic drugs on excitability of guinea pig myocardium. J Mol Cell Cardiol 12:1273–1286
Fleckenstein A (1983) Calcium antagonism in heart and smooth muscle — experimental facts and therapeutic prospects. John Wiley and Sons, New York Chichester Brisbane Toronto Singapore
Gettes LS, Reuter H (1974) Slow recovery from inactivation of inward currents in mammalian myocardial fibres. J Physiol 240: 703–724
Gintant, GA, Hoffman BF, Naylor RE (1983) The influence of molecular form of local anaesthetic type antiarrhythmic agents on reduction of the maximum upstroke velocity of canine cardiac purkinje fibres. Circ Res 52:735–146
Haas HG, Kern R, Einwächter HM, Tarr M (1971) Kinetics of Na inactivation in frog atria. Pflügers Arch 323:141–157
Heistracher P (1971) Mechanism of action of antifibrillatory drugs. Naunyn-Schmiedeberg's Arch Pharmacol 269:199–211
Hille B (1977) Local anesthetics: Hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69:497–515
Hohnloser S, Weirich J, Antoni H (1982) Effects of mexiletine on steady-state characterics and recovery kinetics of \(\dot V_{max} \) and conduction velocity in guinea pig myocardium. J Cardiovasc Pharmacol 4:232–239
Hondeghem LM (1978) Validity of \(\dot V_{max} \) as a measure of the sodium current in cardiac and nervous tissues. Biophys J 23:147–152
Hondeghem LM, Katzung BG (1977) Time- and voltage dependent interaction of antiarrhytmic drugs with cardiac sodium channels. Biochim Biophys Acta 472:373–398
Kishida H, Surawicz B, Fu LT (1979) Effects of K+ and K+-induced polarization on (dV/dt)max, threshold potential, and membrane input resistance in guinea pig and cat ventricular myocardium. Circ Res 44:800–814
Kohlhardt M, Seifert C (1983) Tonic and phasic I Na blockade by antiarrhythmics: Different properties of drug binding to fast sodium channels as judged from \(\dot V_{max} \) studies with propafenone and derivatives in mammalian ventricular myocardium. Pflügers Arch 396:199–209
Mascher D (1970) Electrical and mechanical responses from ventricular muscle fibres after inactivation of the sodium carrying system. Pflügers Arch 317:359–372
Moe GK (1975) Evidence for reentry as a mechanism of cardiac arrhythmias. Rev Physiol Biochem Pharmacol 72:55–81
Rüdiger HJ, Homburger H, Antoni H (1981) Effects of a new antiarrhythmic compouund (2-benzal-l-2′diisopropyl-amino-ethoxy-imino-cycloheptane hydrogen fumarate) on the electrophysiological properties of mammalian cardiac cells. Naunyn-Schmiedeberg's Arch Pharmacol 317:238–244
Saikawa T, Carmeliet E (1982) Slow recovery of the maximal rate of rise (\(\dot V_{max} \)) of the action potential in sheep cardiac Purkinje fibres. Pflügers Arch 394:90–93
Strichartz GR, Cohen I (1978) 162-7 as a measure of 162-8 in nerve and cardiac membranes. Biophys J 23:153–156
Vaughan Williams EM (1970) Classification of antiarrhytmic drugs. In: Sandøe E, Flensted-Jensen E, Olesen KH (eds) Symposium on cardiac arrhythmias, Elsinore, Denmark. AB Astra, Södertälje, Sweden, pp 449–469
Wagner B, Müller VO (1983) Effects of the new antiarrhythmic drug asocainol on isolated guinea pig atria and various smooth muscle preparations. Naunyn-Schmiedeberg's Arch Pharmacol 324:R 37
Wagner B, Satzinger G, Fritschi E, Ganser V, Steinbrecher W (1982) Antiarrhytmic profile of goe 4704-A and its optical isomers goe 3764-A and goe 4474-A in different models and species. Naunyn-Schmiedeberg's Arch Pharmacol 319:R 37
Wallwitz R (1982) Praxisbezogene Anwendung der Microcomputer in der Naturwissenschaft. Luther-Verlag, Sprendlingen
Weidmann S (1955) The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system. J Physiol 127:213–224
Weirich J (1983) Elektrophysiologische Untersuchungen zur Bedeutung gehäufter Extrasystolen für die Flimmerentstehung. Cardiology 70:19–27
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Langenfeld, H., Haverkampf, K. & Antoni, H. Electrophysiological profile of the antiarrhythmic compound asocainol studied on perfused guinea-pig hearts and on isolated cardiac preparations. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 155–162 (1984). https://doi.org/10.1007/BF00517313
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00517313